CHIRAL PHARMACEUTICALS - SCALE-UP, CONTROL AND ITS SIGNIFICANCE FOR DRUG RESEARCH

被引:6
作者
FEDERSEL, HJ
机构
关键词
D O I
10.1002/ciuz.19930270205
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:78 / 87
页数:10
相关论文
共 49 条
[1]  
Allenmark S. G., 1988, CHROMATOGRAPHIC ENAN
[2]   STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[3]   RACEMIC MIXTURES AND SINGLE STEREOISOMERS - INDUSTRIAL CONCERNS AND ISSUES IN DRUG DEVELOPMENT [J].
CAYEN, MN .
CHIRALITY, 1991, 3 (02) :94-98
[4]  
Collins A. N., 1992, CHIRALITY IND THE CO
[5]   SYNTHETIC ENZYMES .4. HIGHLY ENANTIOSELECTIVE EPOXIDATION BY MEANS OF POLYAMINOACIDS IN A TRIPHASE SYSTEM - INFLUENCE OF STRUCTURAL VARIATIONS WITHIN THE CATALYSTS [J].
COLONNA, S ;
MOLINARI, H ;
BANFI, S ;
JULIA, S ;
MASANA, J ;
ALVAREZ, A .
TETRAHEDRON, 1983, 39 (09) :1635-1641
[6]   ON THE ORIGIN OF ENANTIOSELECTIVITY IN THE KATSUKI-SHARPLESS EPOXIDATION PROCEDURE [J].
COREY, EJ .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (06) :1693-1694
[7]   SYNTHESIS OF OPTICALLY-ACTIVE COMPOUNDS - A LARGE-SCALE PERSPECTIVE [J].
CROSBY, J .
TETRAHEDRON, 1991, 47 (27) :4789-4846
[8]   THE RELEVANCE OF CHIRALITY TO THE STUDY OF BIOLOGICAL-ACTIVITY [J].
CROSSLEY, R .
TETRAHEDRON, 1992, 48 (38) :8155-8178
[9]   THE FDA PERSPECTIVE ON THE DEVELOPMENT OF STEREOISOMERS [J].
DECAMP, WH .
CHIRALITY, 1989, 1 (01) :2-6
[10]   SEPARATION OF AMINO-ACID ENANTIOMERS AND CHIRAL AMINES USING PRECOLUMN DERIVATIZATION WITH (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE AND REVERSED-PHASE LIQUID-CHROMATOGRAPHY [J].
EINARSSON, S ;
JOSEFSSON, B ;
MOLLER, P ;
SANCHEZ, D .
ANALYTICAL CHEMISTRY, 1987, 59 (08) :1191-1195